Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Other Income/Expenses (Net)
-$604.00M
Quarterly · Period ending: · USD

TEVA Other Income/Expenses (Net)
Latest reported-$604.00Mperiod ending
Latest reported-$604.00Mperiod ending
TEVA Quarterly Other Income/Expenses (Net) (-$22.80M → -$604.00M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
TEVA other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -5,936,000 | |
| -6,692,000 | |
| 29,922,000 | |
| -12,995,000 | |
| -46,417,000 | |
| -7,054,000 | |
| -9,478,000 | |
| -20,642,000 | |
| -3,340,000 | |
| -3,320,000 | |
| -35,200,000 | |
| -5,400,000 | |
| -1,500,000 | |
| -2,900,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -250,200,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 192,300,000 | |
| -78,700,000 | |
| -77,800,000 | |
| -87,300,000 | |
| 148,800,000 | |
| -62,600,000 | |
| -69,600,000 | |
| -65,700,000 | |
| 151,600,000 | |
| -63,800,000 | |
| -68,800,000 | |
| -68,200,000 | |
| 122,200,000 | |
| -46,600,000 | |
| -50,100,000 | |
| -50,000,000 | |
| -28,500,000 | |
| -26,400,000 | |
| -34,900,000 | |
| -34,900,000 | |
| -34,900,000 | |
| 56,500,000 | |
| -22,800,000 | |
| -22,800,000 |